Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program

International Journal of Cardiology

Volumn 187, Issue 1, 2015, Pages 614-619

  Michal, Matthias ^a,b   Prochaska, Jürgen H ^a   Keller, Karsten ^a   Göbel, Sebastian ^a,b   Coldewey, Meike ^a   Ullmann, Alexander ^a   Schulz, Andreas ^a   Lamparter, Heidrun ^a   Münzel, Thomas ^a,b   Reiner, Iris ^a   Beutel, Manfred E ^a   Wild, Philipp S ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Anxiety; Depression; Mortality; Oral anticoagulation; Patient Health Questionnaire (PHQ); Screening

Indexed keywords

ANTIVITAMIN K; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTICOAGULANT AGENT; VITAMIN K GROUP;

AGE; AGED; ANTICOAGULATION; ANXIETY; ARTICLE; BARTHEL INDEX; CEREBROVASCULAR ACCIDENT; CHARLSON COMORBIDITY INDEX; DEPRESSION; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; OBESITY; OBSERVATIONAL STUDY; PATIENT HEALTH QUESTIONNAIRE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; SYMPTOMATOLOGY; TRANSIENT ISCHEMIC ATTACK; ANTAGONISTS AND INHIBITORS; ANXIETY DISORDER; CARDIOVASCULAR DISEASES; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRE; SICKNESS IMPACT PROFILE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANXIETY DISORDERS; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; SICKNESS IMPACT PROFILE; SURVEYS AND QUESTIONNAIRES; VITAMIN K;

EID: 84929359356     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.374     Document Type: Article

References (37)

1. J.H. Prochaska, M. Coldewey, S. Gobel, K. Keller, M. Hendelmeier, S. Konstantinides, et al., Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme, Eur. J. Prev. Cardiol. (2014). http://dx.doi.org/10.1177/2047487314527852.
2. W.J. Katon, Epidemiology and treatment of depression in patients with chronic medical illness, Dialogues Clin. Neurosci. 13 (2011) 7-23.
3. P. Cuijpers, N. Vogelzangs, J. Twisk, A. Kleiboer, J. Li, B.W. Penninx, Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both, Br. J. Psychiatry 202 (2013) 22-27.
4. P. Rucci, S. Gherardi, M. Tansella, M. Piccinelli, D. Berardi, G. Bisoffi, et al., Subthreshold psychiatric disorders in primary care: prevalence and associated characteristics, J. Affect. Disord. 76 (2003) 171-181.
5. T. Tolmunen, S.M. Lehto, J. Julkunen, J. Hintikka, J. Kauhanen, Trait anxiety and somatic concerns associate with increased mortality risk: a 23-year follow-up in aging men, Ann. Epidemiol. 24 (2014) 463-468.
6. I. Carriere, J. Ryan, J. Norton, J. Scali, R. Stewart, K. Ritchie, et al., Anxiety and mortality risk in community-dwelling elderly people, Br. J. Psychiatry 203 (2013) 303-309.
7. P. Cuijpers, N. Vogelzangs, J. Twisk, A. Kleiboer, J. Li, B.W. Penninx, Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses, Am. J. Psychiatry 171 (2014) 453-462.
8. J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, W.M. Verschuren, et al., European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts), Int. J. Behav. Med. 19 (2012) 403-488.
9. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole- Wilson, et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM), Eur. Heart J. 29 (2008) 2388-2442.
10. J.H. Lichtman, J.T. Bigger Jr., J.A. Blumenthal, N. Frasure-Smith, P.G. Kaufmann, F. Lesperance, et al., Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association, Circulation 118 (2008) 1768-1775.
11. B. Löwe, I. Wahl, M. Rose, C. Spitzer, H. Glaesmer, K. Wingenfeld, et al., A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population, J. Affect. Disord. 122 (2010) 86-95.
12. K. Kroenke, R.L. Spitzer, J.B. Williams, B. Lowe, An ultra-brief screening scale for anxiety and depression: the PHQ-4, Psychosomatics 50 (2009) 613-621.
13. S.S. Pedersen, J. Denollet, P. de Jonge, C. Simsek, P.W. Serruys, R.T. van Domburg, Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting, J. Gen. Intern. Med. 24 (2009) 1037-1042.
14. B.L. Rollman, B. Herbeck Belnap, S. Mazumdar, P.R. Houck, F. He, R.J. Alvarez, et al., A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality, J. Card. Fail. 18 (2012) 238-245.
15. C.M. Celano, L. Suarez, C. Mastromauro, J.L. Januzzi, J.C. Huffman, Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease, Circ. Cardiovasc. Qual. Outcomes 6 (2013) 498-504.
16. C. Diez-Quevedo, J. Lupon, B. Gonzalez, A. Urrutia, L. Cano, R. Cabanes, et al., Depression, antidepressants, and long-term mortality in heart failure, Int. J. Cardiol. 167 (2013) 1217-1225.
17. I. Jaussent, M.L. Ancelin, C. Berr, K. Peres, J. Scali, A. Besset, et al., Hypnotics and mortality in an elderly general population: a 12-year prospective study, BMC Med. 11 (2013) 212.
18. K. Kroenke, R.L. Spitzer, J.B. Williams, The Patient Health Questionnaire-2: validity of a two-item depression screener, Med. Care 41 (2003) 1284-1292.
19. B.D. Thombs, R.C. Ziegelstein, M.A. Whooley, Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study, J. Gen. Intern. Med. 23 (2008) 2014-2017.
20. P. Skapinakis, The 2-item Generalized Anxiety Disorder scale had high sensitivity and specificity for detecting GAD in primary care, Evid. Based Med. 12 (2007) 149.
21. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, et al., Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur. Heart J. 31 (2010) 2369-2429.
22. P. Gastelurrutia, J. Lupon, S. Altimir, M. de Antonio, B. Gonzalez, R. Cabanes, et al., Fragility is a key determinant of survival in heart failure patients, Int. J. Cardiol. 175 (2014) 62-66.
23. M.E. Charlson, P. Pompei, K.L. Ales, C.R. MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J. Chronic Dis. 40 (1987) 373-383.
24. S.R. Erickson, E. Cole, E. Kline-Rogers, K.A. Eagle, The addition of the Charlson Comorbidity Index to the GRACE Risk Prediction Index improves prediction of outcomes in acute coronary syndrome, Popul. Health Manag. 17 (2014) 54-59.
25. S.P. Bhavnani, C.I. Coleman, D. Guertin, R.K. Yarlagadda, C.A. Clyne, J. Kluger, Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patients, Ann. Noninvasive Electrocardiol. 18 (2013) 379-388.
26. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, E. Briet, A method to determine the optimal intensity of oral anticoagulant therapy, Thromb. Haemost. 69 (1993) 236-239.
27. M. Michal, J.H. Prochaska, A. Ullmann, K. Keller, S. Gobel, M. Coldewey, et al., Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program, J. Thromb. Haemost. 12 (2014) 2024-2033.
28. B. Löwe, K. Kroenke, K. Gräfe, Detecting and monitoring depression with a two-item questionnaire (PHQ-2), J. Psychosom. Res. 58 (2005) 163-171.
29. B.D. Thombs, M. Roseman, J.C. Coyne, P. de Jonge, V.C. Delisle, E. Arthurs, et al., Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review, PLoS One 8 (2013) e52654.
30. J.C. Huffman, C.A. Mastromauro, G. Sowden, G.L. Fricchione, B.C. Healy, J.L. Januzzi, Impact of a depression care management program for hospitalized cardiac patients, Circ. Cardiovasc. Qual. Outcomes 4 (2011) 198-205.
31. W. Katon, Collaborative depression care models: from development to dissemination, Am. J. Prev. Med. 42 (2012) 550-552.
32. M. van den Berg, F. Smit, T. Vos, P.H. van Baal, Cost-effectiveness of opportunistic screening and minimal contact psychotherapy to prevent depression in primary care patients, PLoS One 6 (2011) e22884.
33. J.C. Huffman, C.A. Mastromauro, S.R. Beach, C.M. Celano, C.M. DuBois, B.C. Healy, et al., Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial, JAMA Intern. Med. 174 (2014) 927-936.
34. P. Cuijpers, N. Vogelzangs, J. Twisk, A. Kleiboer, J. Li, B.W. Penninx, Is excess mortality higher in depressed men than in depressed women? A meta-analytic comparison, J. Affect. Disord. 161 (2014) 47-54.
35. R.M. Carney, K.E. Freedland, Treatment-resistant depression and mortality after acute coronary syndrome, Am. J. Psychiatry 166 (2009) 410-417.
36. J.H. Lichtman, E.S. Froelicher, J.A. Blumenthal, R.M. Carney, L.V. Doering, N. Frasure- Smith, et al., Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association, Circulation 129 (2014) 1350-1369.
37. K.H. Ladwig, F. Lederbogen, C. Albus, C. Angermann, M. Borggrefe, D. Fischer, et al., Position paper on the importance of psychosocial factors in cardiology: update 2013, Ger. Med. Sci. 12 (2014) (Doc09).